Egalet (STU:EGP) Float Percentage Of Total Shares Outstanding: 92.57% (As of Jul. 09, 2026)


What is Egalet Float Percentage Of Total Shares Outstanding?

Egalet STU:EGP Float Percentage Of Total Shares Outstanding is 92.57% as of Jul. 09, 2026. The stock has 2 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Egalet's float shares is 52.55 Mil. Egalet's total shares outstanding is 56.77 Mil. Egalet's float percentage of total shares outstanding is 92.57%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Egalet's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Egalet's Institutional Ownership is 7.55%.

Egalet Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Egalet's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=52.55/56.77
=92.57%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 92.57% mean?
Egalet (STU:EGP) has a Float Percentage Of Total Shares Outstanding of 92.57% as of Jul. 09, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Egalet and its competitors.
Is Egalet's Float Percentage Of Total Shares Outstanding too high?
Egalet's current Float Percentage Of Total Shares Outstanding is 92.57%.
How does Egalet's Float Percentage Of Total Shares Outstanding compare to CPHI and TLGT?
Egalet's Float Percentage Of Total Shares Outstanding of 92.57% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Drug Manufacturers company?
A good Float Percentage Of Total Shares Outstanding depends on the Drug Manufacturers industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Egalet and its competitors. Egalet's current Float Percentage Of Total Shares Outstanding is 92.57%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Egalet stock overvalued right now?
Egalet (STU:EGP) has a current Float Percentage Of Total Shares Outstanding of 92.57%. The current Float Percentage Of Total Shares Outstanding is 92.57%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Egalet (STU:EGP), the current Float Percentage Of Total Shares Outstanding is 92.57% as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Egalet Business Description

Address 600 Lee Road, Suite 100, Wayne, PA, USA, 19087
Zyla Life Sciences is a U.S based company focused on marketing its portfolio of medicines for pain and inflammation. The products offered by the company include Sprix, Oxaydo, Vivlodex, Zorvolex, Tivorbex and Indocin Oral Suspension among others.